- Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc (ILMN.O), arguing that the life science maker's acquisition of Grail Inc (GRAL.O) cost its shareholders roughly $50 billion.
- European Commission ordered Illumina in December to unwind the deal, three months after it had blocked the merger on concerns the deal would stifle innovation.
- Icahn plans to nominate three people to Illumina's board.
Carl Icahn prepares for proxy fight at Illumina - WSJ
Activist investor Carl Icahn is preparing a proxy fight at Illumina Inc , arguing that the life science maker's acquisition of Grail Inc cost its shareholders roughly $50 billion, the Wall Street Journal reported on Sunday.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/FKA4GFPZHNOYVOYCH6VMMN4AXE.jpg)